Substandard Drugs from MSME Pharma Sector Pose Public Health Risks
India's MSME pharmaceutical sector faces scrutiny as over 65% of firms are found manufacturing substandard drugs, prompting nation...
India's MSME pharmaceutical sector faces scrutiny as over 65% of firms are found manufacturing substandard drugs, prompting nation...